Alginate as an Efficacious Treatment for GERD Patients: A Literature Review
DOI:
https://doi.org/10.56260/sciena.v4i2.201Keywords:
Alginate, GERD, refluxAbstract
Gastroesophageal reflux disease (GERD) is a medical condition defined by the retrograde flow of gastric contents into the esophagus, leading to various symptoms. The principal therapy for GERD consists of proton pump inhibitors (PPIs). Nevertheless, PPIs demonstrate reduced effectiveness in patients with non-erosive GERD or unusual symptoms. Alginates operate by forming a gel "raft" that floats on the gastric contents, serving as a physical barrier against reflux. Multiple studies demonstrate that alginate is more effective than antacids in alleviating GERD symptoms and has a longer duration of action.
References
. Siagian BNIF, Girsang E. Identification Of Drug Use In Gastroesophageal Reflux Disease (Gerd) Patients In Outstanding Installation Royal Prima Hospital. Journal Health & Science : Gorontalo Journal Health and Science Community 2022; 6: 187–201.
. Clarrett DM, Hachem C. Gastroesophageal Reflux Disease (GERD). Mo Med 2018; 115: 214–218.
. Indonesian Society of Gastroenterology. National consensus on the management of gastroesophageal reflux disease in Indonesia. Acta Med Indones 2014; 46: 263–71.
. Leiman DA, Riff BP, Morgan S, et al. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis. Diseases of the Esophagus 2017; 30: 1–9.
. Perkumpulan Gastroenterologi Indonesia (PGI). Konsensus Nasional Penatalaksanaan Penyakit Refluks Gastroesofageal (Gastroesophageal Reflux Disease GERD) di Indonesia (Revisi 2022). Jakarta Pusat: PIP Interna, 2022.
. Miwa H, Kondo T, Oshima T. Gastroesophageal reflux disease-related and functional heartburn. Curr Opin Gastroenterol 2016; 32: 344–352.
. Menezes MA, Herbella FAM. Pathophysiology of Gastroesophageal Reflux Disease. World J Surg 2017; 41: 1666–1671.
. Oshima T, Koseki J, Chen X, et al. Acid modulates the squamous epithelial barrier function by modulating the localization of claudins in the superficial layers. Laboratory Investigation 2012; 92: 22–31.
. Jung HK, Tae CH, Song KH, et al. 2020 Seoul consensus on the diagnosis and management of gastroesophageal reflux disease. Journal of Neurogastroenterology and Motility 2021; 27: 453–481.
. Boeckxstaens GE, Rohof WO. Pathophysiology of Gastroesophageal Reflux Disease. Gastroenterol Clin North Am 2014; 43: 15–25.
. Tack J, Pandolfino JE. Pathophysiology of Gastroesophageal Reflux Disease. Gastroenterology 2018; 154: 277–288.
. Ayazi S, Hagen JA, Chan LS, et al. Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms. J Gastrointest Surg 2009; 13: 1440–1447.
. Roman S, Holloway R, Keller J, et al. Validation of criteria for the definition of transient lower esophageal sphincter relaxations using high‐resolution manometry. Neurogastroenterology & Motility; 29. Epub ahead of print 31 February 2017. DOI: 10.1111/nmo.12920.
. Mittal RK, Karstens A, Leslie E, et al. Ambulatory high-resolution manometry, lower esophageal sphincter lift and transient lower esophageal sphincter relaxation. Neurogastroenterology & Motility 2012; 24: 40-e2.
. Altan E, Blondeau K, Pauwels A, et al. Evolving pharmacological approaches in gastroesophageal reflux disease. Expert Opin Emerg Drugs 2012; 17: 347–359.
. Tokashiki R, Funato N, Suzuki M. Globus sensation and increased upper esophageal sphincter pressure with distal esophageal acid perfusion. European Archives of Oto-Rhino-Laryngology 2010; 267: 737–741.
. Dent J. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 2004; 53: iv1–iv24.
. Gyawali CP, Fass R. Management of Gastroesophageal Reflux Disease. Gastroenterology 2018; 154: 302–318.
. Kroch DA, Madanick RD. Medical Treatment of Gastroesophageal Reflux Disease. World J Surg 2017; 41: 1678–1684.
. Mandel KG, Daggy BP, Brodie DA, et al. Review article: Alginate-raft formulations in the treatment of heartburn and acid reflux. Alimentary Pharmacology and Therapeutics 2000; 14: 669–690.
. Bor S, Kalkan İH, Çelebi A, et al. Alginates: From the ocean to gastroesophageal reflux disease treatment. Turkish Journal of Gastroenterology 2019; 30: S109–S136.
. SINGEAP A-M, HUIBAN L, CHIRIAC S, et al. The role of alginate-based therapy in gastroesophageal reflux disease. Romanian Journal of Medical Practice 2020; 15: 285–291.
. Rohof WO, Bennink RJ, Smout AJPM, et al. An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease. Clinical Gastroenterology and Hepatology 2013; 11: 1585–1591.
. Malmud LS, Charkes ND, Littlefield J, et al. The Mode of Action of Alginic Acid Compound in the Reduction of Gastroesophageal Reflux. Journal of Nuclear Medicine; 20.
. Fox MR, Kant R, Kaufman E, et al. The Mechanism of Reflux Suppression by Alginates Assessed by Magnetic Resonance Imaging and Manometry. Gastroenterology 2011; 140: S-576-S-577.
. Salvatore S, Ripepi A, Huysentruyt K, et al. The Effect of Alginate in Gastroesophageal Reflux in Infants. Pediatric Drugs 2018; 20: 575–583.
. C.-X Z, J.-W W, M. Gong. Efficacy and safety of alginate formulations in patients with gastroesophageal reflux disease: a systematic review and meta-analysis of randomized controlled trials. Eur Rev Med Pharmacol Sci 2020; 24: 11845–11857.
. Giannini EG, Zentilin P, Dulbecco P, et al. A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. Dig Dis Sci 2006; 51: 1904–1909.
. Pouchain D, Bigard MA, Liard F, et al. Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial. BMC Gastroenterol; 12. Epub ahead of print 23 February 2012. DOI: 10.1186/1471-230X-12-18.
. Lai IR, Wu MS, Lin JT. Prospective, randomized, and active controlled study of the efficacy of alginic acid and antacid in the treatment of patients with endoscopy-negative reflux disease. World J Gastroenterol 2006; 12: 747–754.
. Hasni, D., Ellia, R., Khalila, A. S., & Anggraini, D. (2023). The Relationship Between Diet and Nutritional Status Balance in Adolescents. Nusantara Hasana Journal, 3(6), 159-173.
. Dana, T. S., Ivan, M., & Anggraini, D. (2024). Hubungan Obesitas Terhadap Kejadian Gastroesophageal Reflux Disease pada Mahasiswa Fakultas Kedokteran Universitas Baiturrahmah. Scientific Journal, 3(1), 01-07.
. Ilham, D., Anggraini, D., & Oktora, M. Z. (2024). HUBUNGAN POLA MAKAN TERHADAP KEJADIAN GASTROESOPHAGEAL REFLUX DISEASE PADA MAHASISWA KEDOKTERAN UNIVERSITAS BAITURRAHMAH. Journal of Public Health Science, 1(3), 163-169.
. Supardi, MM., Anggraini, D., Hamda, R. (2024). hubungan mengonsumsi kopi dengan kejadian GERD Pada Mahasiswa Kedokteran universitas baiturrahmah angkatan 2020. Jurnal of public health. 1(3), 170-177
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Ninda Septia Yuspar, Suyata
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
